DCP
ROIVW

Diameter Capital Partners’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Diameter Capital Partners’s Portfolio ROIVW Stock Details ROIVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-100,000
Closed -$205K – 113
2021
Q4 		$205K Buy
+100,000
New +$153K 0.01% 126

Other funds holding ROIVW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SAM
Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Diameter Capital Partners's ROIVW Position: Q1 2022 in Review

Diameter Capital Partners sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q1 2022, closing a stake of 100,000 shares — an estimated $205K sold.

Diameter Capital Partners first reported a position in ROIVW in Q4 2021 and held it in 1 quarter. The position peaked at $205K in Q4 2021. 36 funds tracked by Wall St. Rank hold ROIVW as of Q1 2022.

  • Diameter Capital Partners reported no remaining Roivant Sciences Ltd. Warrant position as of Q1 2022 after selling out during the quarter.
  • Diameter Capital Partners sold 100,000 Roivant Sciences Ltd. Warrant shares in Q1 2022, an estimated $205K.
  • Diameter Capital Partners first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 1 quarter.
  • Diameter Capital Partners's Roivant Sciences Ltd. Warrant position peaked at $205K in Q4 2021.
  • 36 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q1 2022.

Based on Diameter Capital Partners's 13F filing for Q1 2022, filed 16 May 2022.